Yamamoto, Hiroshi

The reeler gene-associated antigen on cajal-retzius neurons is a crucial molecule for laminar organization of cortical neurons

Ogawa, M., Miyata, T., Nakajimat, K., Yagyu, K., Seike, M., Ikenaka, K., Yamamoto, H., & Mikoshibat, K. (1995) · Neuron

Neurogenesis and neuroplasticity mechanismsAxon Guidance and Neuronal Signaling

Cited by 889

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal

Advanced Glycation End Products researchRetinal Diseases and Treatments

Cited by 716

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 475

Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS

Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. (2011) · The Journal of Immunology

Advanced Glycation End Products researchImmune Response and Inflammation

Cited by 207

RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication

Yamamoto, Y., & Yamamoto, H. (2013) · Frontiers in Endocrinology

Advanced Glycation End Products researchAdipokines, Inflammation, and Metabolic Diseases

Cited by 99

Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse

Ueno, H., Koyama, H., Shoji, T., Monden, M., Fukumoto, S., Tanaka, S., Otsuka, Y., Mima, Y., Morioka, T., Mori, K., et al. (2010) · Atherosclerosis

Advanced Glycation End Products researchAdipokines, Inflammation, and Metabolic Diseases

Cited by 65

RAGE mediates vascular injury and inflammation after global cerebral ischemia

Kamide, T., Kitao, Y., Takeichi, T., Okada, A., Mohri, H., Schmidt, A. M., Kawano, T., Munesue, S., Yamamoto, Y., Yamamoto, H., et al. (2012) · Neurochemistry International

Advanced Glycation End Products researchNeurological Disease Mechanisms and Treatments

Cited by 60

Protein Synthesis in the Developing Neocortex at Near-Atomic Resolution Reveals Ebp1-Mediated Neuronal Proteostasis at the 60S Tunnel Exit

Kraushar, M. L., Krupp, F., Harnett, D., Turko, P., Ambrozkiewicz, M. C., Sprink, T., Imami, K., Günnigmann, M., Zinnall, U., Vieira-Vieira, C. H., et al. (2021) · Molecular Cell

RNA and protein synthesis mechanismsGenetics and Neurodevelopmental Disorders

Cited by 49

Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells

Yamamoto, Y., Yonekura, H., Watanabe, T., Sakurai, S., Li, H., Harashima, A., Myint, K. M., Osawa, M., Takeuchi, A., Takeuchi, M., et al. (2007) · Diabetes Research and Clinical Practice

Advanced Glycation End Products researchRetinal Diseases and Treatments

Cited by 44

Deletion of RAGE Causes Hyperactivity and Increased Sensitivity to Auditory Stimuli in Mice

Sakatani, S., Yamada, K., Homma, C., Munesue, S., Yamamoto, Y., Yamamoto, H., & Hirase, H. (2009) · PLoS ONE

Advanced Glycation End Products researchNeuroscience and Neuropharmacology Research

Cited by 42

cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products

Motoyoshi, S., Yamamoto, Y., Munesue, S., Igawa, H., Harashima, A., Saito, H., Han, D., Watanabe, T., Sato, H., & Yamamoto, H. (2014) · Biochemical Journal

Advanced Glycation End Products researchImmune Response and Inflammation

Cited by 20